FORM 8-K

Company

GT Biopharma, Inc.

Filed

January 4, 2005

Period of Report

December 30, 2004

Accession Number

0001193125-05-000752

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →